Home/Filings/4/0001213900-22-062485
4//SEC Filing

Kane William 4

Accession 0001213900-22-062485

CIK 0001506251other

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 4:10 PM ET

Size

19.3 KB

Accession

0001213900-22-062485

Insider Transaction Report

Form 4
Period: 2022-10-04
Kane William
Director
Transactions
  • Award

    Options to Purchase Common Stock

    2022-10-04+75,00075,000 total
    Exercise: $1.25Exp: 2032-10-04Common Stock (75,000 underlying)
Holdings
  • Options to Purchase Common Stock

    Exercise: $0.01Exp: 2024-03-28Common Stock (12,071 underlying)
    12,071
  • Options to Purchase Common Stock

    Exercise: $1.01Exp: 2030-10-06Common Stock (35,000 underlying)
    35,000
  • Options to Purchase Common Stock

    Exercise: $1.39Exp: 2030-07-07Common Stock (25,000 underlying)
    25,000
  • Options to Purchase Common Stock

    Exercise: $2.04Exp: 2031-10-11Common Stock (75,000 underlying)
    75,000
  • Options to Purchase Common Stock

    Exercise: $1.69Exp: 2031-02-16Common Stock (25,000 underlying)
    25,000
  • Options to Purchase Common Stock

    Exercise: $0.67Exp: 2029-10-08Common Stock (25,000 underlying)
    25,000
  • Options to Purchase Common Stock

    Exercise: $1.62Exp: 2028-09-04Common Stock (15,000 underlying)
    15,000
  • Options to Purchase Common Stock

    Exercise: $2.00Exp: 2031-07-22Common Stock (15,000 underlying)
    15,000
  • Options to Purchase Common Stock

    Exercise: $3.45Exp: 2027-09-13Common Stock (10,000 underlying)
    10,000
  • Options to Purchase Common Stock

    Exercise: $12.00Exp: 2026-06-23Common Stock (13,334 underlying)
    13,334
Footnotes (11)
  • [F1]The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
  • [F10]The options vested in 1/3 increments over a three-year period with the first installment vesting on March 28, 2015.
  • [F11]The options vested in full on the first anniversary of the date of grant.
  • [F2]The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
  • [F3]The options vested in full on July 22, 2022.
  • [F4]The options vested in full on February 16, 2022.
  • [F5]The options vested in full on October 6, 2021.
  • [F6]The options vested in full on July 7, 2021.
  • [F7]The options vested in full on October 8, 2020.
  • [F8]The options vested in full on September 4, 2019.
  • [F9]The options vested in full on September 13, 2018.

Documents

1 file

Issuer

Citius Pharmaceuticals, Inc.

CIK 0001506251

Entity typeother

Related Parties

1
  • filerCIK 0001671585

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:10 PM ET
Size
19.3 KB